60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$0.89 +0.00 (+0.05%)
As of: Oct 22, 2026 · 11:33 AM EDT

60 Degrees Pharmaceuticals (SXTP) Long-Term Debt Repayments (2023)

Updated

60 Degrees Pharmaceuticals (SXTP) reported Long-Term Debt Repayments of $1.61 million for FY2023.

Analysis

60 Degrees Pharmaceuticals (SXTP) Long-Term Debt Repayments (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,176.80 Bn 1,145.39 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 2.00 Bn
4 Merck 376.70 Bn 331.08 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 268.37 Bn 242.05 Bn 12.86 Bn 2.46 Bn
7 Amgen 242.34 Bn 197.74 Bn 7.24 Bn -
8 Gilead Sciences 193.58 Bn 167.78 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.88 Bn 119.53 Bn 10.94 Bn -
10 60 Degrees Pharmaceuticals 2.41 Mn 1.39 Mn 56,798.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 1.61 Mn
API Access

60 Degrees Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SXTP&period=max&api_key=YOUR_API_KEY